Silencing GPC3 in hepatocytes from proximal liver tissue and human HCC cells, with a targeted siRNA, was shown to decrease proliferation and boost apoptosis, along with a decrease in the invasive profile [44]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.